20th International Conference


Diabetes and Endocrinology

Event Date

April 25-26, 2024


Barcelona, Spain


– Previous Conference Performers / Professionals From Around The Globe

Aikaterini Ziaka

Physio4you, Greece

Elizabeth Mahon

Liverpool John Moores University, United Kingdom

Farah naaz Kazi

United Kingdom

Huang Wei Ling, MD,


Michael Fossel

Michigan State University , USA

Iskandar r Budianto 

Atma jaya University. Jakarta

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia

Jorge Arturo Hernandez 


Nkechi M Enwerem, 

Harvard University,USA

Said El deib

YAS Clinic , UAE

Sandra Velez-Candelario

Family Organizational Psychology LLC, USA

Xu chen


Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!


A huge thanks to all our amazing partners. We couldn’t have a conference without you!


It is an honor and privilege to invite participants from All over the world to attend “20th International Conference on Diabetes And Endocrinology” which is going to be held on April 25-26, 2024 in Barcelona, Spain and incorporates incite keynote introductions, oral talks, and Poster Presentations.

In this Hybrid mode, you have the option to join either in-person in Barcelona, Spain, or virtually from the comfort of your home or workplace.

Meet the Global Inspiring experts and speakers at our World Conference on Diabetes and Endocrinology which will focus on bringing together individuals who have an interest in different fields of Endocrinology, Diabetes, and Metabolic Disorders such as Endocrinologists, Diabetologists, Medical Professors, Researchers, Diabetes and Endocrinology Scientists, Practitioners, Physical trainer, Medical students.
Diabetics Conference 2024  highlights the theme “Technologies and practical approaches: Diabetes and Endocrine disorders” Which emphasizes the latest advancements in prevention and treatment cure of diabetic and endocrine complications and strategies related to diagnosis, prevention, and management of metabolic disorders as well as explores new ideas and concepts for the treatment of Endocrine Complications.

Why attend?

Medical doctors, patients, and health care providers examine the prevention of Endocrinology as an essential tool to improve the general health status of the population. The proportions of people suffering from Diabetes are expected to increase in the future according to a recent analytical survey. Realizing this imperative, it was set to establish an International Conference on Diabetes, Endocrinology, and Metabolism with a view to enhance research and promote awareness aiming in developing solutions for the challenges encountered.

Benefits of Attending Diabetics Conference 2024

  • Communicate ideas and network with leading diabetologists, endocrinologists, diabetes researchers, clinician’s researchers, diabetes and endocrinology professionals, and also researchers from more than 40 countries.
  • Discuss ways to hook up in putting quality initiatives in place throughout diabetes, endocrinology and metabolism study, and diabetes & endocrinology disorders and treatment.
  • Participants can attain direct access to a core audience of professionals and decision-makers and can increase clarity through branding and networking at the conference.
  • Prepare and discuss key news and challenges with senior-level speakers.
  • With presentations, panel discussions, roundtable discussions, and workshops, we cover each and every topic from global macro issues to approaches to diplomatic issues.

Highlights of the Diabetics Conference 2024

Target Audience

Sessions and Tracks 

Diabetes Mellitus (DM), commonly known as diabetes, is a metabolic disorder characterized by prolonged high glucose levels. It is a multifactorial condition influenced by both genetic and environmental factors. Insulin, produced by beta cells, facilitates glucose activation within body cells. High glucose levels result from insulin resistance or inadequate insulin production. Symptoms include excessive urination, thirst, and hunger. Elevated glucose deposits in heart and kidney vessels can lead to complications such as heart and kidney diseases, and nervous system damage.

Track 2: Types of Diabetes and its Complications

More than 10% of diabetics have type 1 diabetes, an autoimmune condition where insulin-producing cells are attacked. Type 2 diabetes involves insulin resistance, hindering glucose control. Complications may arise from impaired insulin secretion or increased resistance. While type 1 diabetes is often diagnosed in children and teens, type 2 diabetes can develop at any stage in life. Researchers emphasize that preventing type 1 diabetes is challenging, given its immune system origins. In contrast, type 2 diabetes is linked to insulin resistance, where the body does not respond adequately to insulin.

Track 3: Cardio Diabetes

Cardiovascular disease is the leading cause of mortality in patients with type 2 diabetes. Coined as “cardiodiabetes,” this term describes the co-occurrence of diabetes and cardiovascular diseases, contributing to atherosclerosis and coronary heart diseases (CHD). Individuals with diabetes are highly prone to cardiovascular complications such as atherosclerosis, the development of plaque deposits in larger blood vessels, reducing blood flow to the heart and other parts of the body. This can lead to CHD and, in severe cases, result in heart attacks. These complications are responsible for three-quarters of diabetes-related deaths.

Track 4: Pediatric Endocrinology

Endocrine diseases in children and adolescents can lead to severe health issues with long-lasting impacts on physical and mental well-being. Elevated blood glucose levels, often measured by A1C levels, are associated with long-term microvascular and macrovascular complications. Frequent hypoglycemia, especially at a young age, can impact cognitive function and contribute to hypoglycemia ignorance. Serious issues related to obesity and insulin resistance in this age group include polycystic ovary syndrome, fatty liver, dyslipidemia, and hypertension.

Track 5: Endocrinology – Obesity and Lipids

Obesity is a prevalent and escalating health issue with significant implications for cardiovascular health. Overweight and obesity are major risk factors for cardiovascular disease, contributing to dyslipidemia and inflammation, among others. Adiponectin, a hormone released by fat tissue, plays a role in metabolic and anti-inflammatory processes. Studies highlight the relationship between adiponectin and obesity in various human populations. LDL cholesterol is a key player in diabetic dyslipidemia, considered highly atherogenic. The variant VLDL, a low-density lipoprotein, appears particularly hazardous. Despite elevated levels in HDL, high-density lipoprotein cholesterol may moderate its detrimental effects, even without a corresponding drop in LDL numbers.

Track 6: Diabetes and the Kidneys

Nephropathy, also known as kidney damage, is a significant concern for individuals with diabetes. Diabetic nephropathy occurs when the kidneys are damaged by diabetes, leading to two types: nephritis, an inflammatory kidney disease, and nephrosis, a non-inflammatory kidney disease. In severe cases, diabetic nephropathy can progress to kidney failure. The kidneys, responsible for filtering impurities from the blood, have numerous small vessels. High blood glucose levels can damage these vessels, compromising kidney function. Individuals with elevated glucose levels or those who smoke are particularly susceptible to kidney diseases.

Track 7: Diabetic Retinopathy: Causes, symptoms & Treatments

Diabetic retinopathy is a condition that damages the arteries and veins within the retinal tissue, leading to the leakage of fluid and distorted vision. Notably, diabetic retinopathy often begins without any noticeable changes in vision. Managing diabetic retinopathy depends on various factors, including the severity and type of the condition and the individual’s response to previous treatments. Successful management involves actively maintaining glucose levels, which can help prevent the onset of severe forms of diabetic retinopathy.

Track 8: Diabetic Foot Problems

Diabetic foot problems represent one of the most pervasive, costly, and dangerous complications of diabetes. The risk of amputation in individuals with diabetes is 10 to 20 times higher than in those without diabetes. Approximately every 30 seconds, a lower limb or part of a lower limb is lost due to diabetes-related complications. Diabetic foot problems can have significant economic, social, and public health implications, especially in low-income countries where there may be insufficient educational programs and inadequate access to suitable footwear.

Track 9: Metabolic Disorders

Acquired metabolic diseases encompass various clinical conditions resulting from genetic defects, typically inherited from parents. These conditions disrupt the body’s metabolism, a complex system of chemical reactions essential for sustaining life, including energy production. Metabolic disorders often involve specific enzymes that break down food or certain chemicals, enabling the body to utilize them immediately for energy or store them. Additionally, these enzymes help break down substances the body doesn’t need or produce those it lacks. Examples of metabolic disorders include Familial hypercholesterolemia, Gaucher disease, Hunter syndrome, Krabbe disease, among others.

Track 10: Reproductive Endocrinology

Fertilization and pregnancy are pivotal stages in human existence, and their successful navigation is crucial for the health of both the mother and the offspring. Pregnancy, also known as gestation, involves the development of one or more offspring in women. It is a critical period that requires careful management to ensure the well-being of both the mother and the unborn child. Women face an increased risk of developing thyroid issues following infertility, miscarriage, and complications during pregnancy and labor. Thyroid diseases in women can manifest as menstrual cycle irregularities, infertility, and complications during pregnancy.

Track 11: Adrenal Insufficiency and Adrenal Crisis

Adrenal crisis is a severe exacerbation of adrenal insufficiency, resulting from either increased physiologic stress or a diminished supply of cortisol. This crisis typically occurs during significant stressors, such as acute myocardial infarction, sepsis, surgery, major trauma, or other critical illnesses. It is essential to recognize that adrenal insufficiency involves the adrenal glands’ inability to mount a stress response by increasing circulating cortisol levels. One of the most common iatrogenic causes of acute adrenal crisis is the abrupt withdrawal of steroids in patients with adrenal insufficiency secondary to prolonged steroid use.

Track 12: Endocrine Disorders

Endocrine disorders are diseases related to the endocrine glands, which produce hormones crucial for regulating various life processes. Hormones are signaling molecules released into the bloodstream to control processes such as hunger, breathing, growth, fluid balance, menstruation, virilization, and weight control. These disorders can manifest in various ways, affecting the production, release, or action of hormones. Examples of endocrine disorders include diabetes mellitus, acromegaly (overproduction of growth hormone), Addison’s disease (reduced production of hormones by the adrenal glands), Cushing’s syndrome (elevated cortisol levels for an extended period), Graves’ disease (a type of hyperthyroidism resulting in increased thyroid hormone production), Hashimoto’s thyroiditis (an autoimmune disease causing hypothyroidism and reduced thyroid hormone production), hyperthyroidism (overactive thyroid), hypothyroidism (underactive thyroid), and prolactinoma (increased production of prolactin by the pituitary gland).

Track 13: Diabetes and Cancer

Diabetes and cancer are prominent diseases with a significant impact on public health. Epidemiological studies have consistently shown that individuals with diabetes are at a higher risk of developing various types of cancer. While type 2 diabetes and cancer share several risk factors, the biological connections between these two conditions are not fully understood. Observational studies suggest that certain medications used to treat hyperglycemia may be associated with either an increased or decreased risk of cancer. The relationship between diabetes and cancer is complex, involving multiple factors such as insulin resistance, chronic inflammation, and shared genetic predispositions. Understanding these intricate connections is crucial for developing comprehensive strategies for prevention, diagnosis, and treatment.

Track 14: Endocrinology Tests and Procedure

Endocrinology tests and procedures play a crucial role in the diagnosis and management of hormonal disorders. The endocrine system, composed of glands that produce and release hormones, regulates various physiological functions, including metabolism, growth, and reproduction. Testing hormone levels in blood and urine samples helps healthcare professionals assess the functioning of the endocrine system. Imaging tests, such as ultrasound, CT scans, and MRI, may be employed to identify structural abnormalities in endocrine organs, such as tumors. The choice of treatment for endocrine disorders depends on the specific condition and its underlying cause. While some conditions can be managed with medications, others may require surgical interventions. Endocrinologists, specialists in the field of endocrinology, play a crucial role in diagnosing, treating, and managing hormonal imbalances.

Track 15: Diabetes Diet Eating and Physical Activity

Adopting a healthy lifestyle, including a balanced diet and regular physical activity, is paramount in managing and preventing diabetes. The primary goal in treating both type 1 and type 2 diabetes is to control blood glucose levels within normal ranges. Type 1 diabetes is typically managed with insulin, exercise, and a healthy diet. On the other hand, type 2 diabetes treatment involves weight reduction, adherence to a specific diet tailored for type 2 diabetes, and regular exercise. Medications, either oral or injected, may be prescribed if lifestyle modifications are insufficient in controlling elevated blood sugars. In cases where other medications prove inadequate, insulin therapy may be initiated. Non-pharmacological interventions, such as dietary modifications and increased physical activity, play a crucial role in managing diabetes and reducing the reliance on medication.

Track 16: Diabetes Diagnosis and Treatment

Healthcare professionals diagnose different types of diabetes through blood tests that measure blood glucose levels. These tests help determine whether blood glucose, commonly known as blood sugar, is too high or too low. While some individuals may not experience direct symptoms of diabetes, certain indirect risk factors may warrant testing. Timely testing allows medical professionals to detect diabetes early and work with patients to manage the condition effectively, preventing complications. Type 1 diabetes, often with a genetic predisposition, can run in families. Trial Net, a research initiative, offers free testing for relatives of individuals with type 1 diabetes, even if they are asymptomatic. Additionally, healthcare providers recommend testing overweight or obese children between the ages of 10 and 18 who exhibit two or more risk factors for developing diabetes.

Track 17: Diabetic Surgeries

Type 2 Diabetes mellitus is a global health concern affecting over 150 million individuals worldwide. Recognized as a progressive and chronic disease, it poses significant morbidity and mortality risks. Severe obesity, defined as exceeding the ideal weight by at least 100 pounds or being over 200% of the ideal body weight, is associated with high mortality rates due to its connection with serious comorbidities like hypertension, diabetes, hyperlipidemia, and cardiopulmonary failure. Bariatric surgery, a surgical intervention, offers a comprehensive approach to addressing these concerns. The surgery results in substantial and sustained weight loss and resolution or improvement of comorbid conditions. Current indications for surgery

Market Analysis

The Diabetes and Endocrinology Conference in 2024 represents a critical juncture in the healthcare sector, providing a comprehensive platform for professionals, researchers, and industry stakeholders to discuss and address the latest developments in the field. Market analysis indicates a growing demand for conferences dedicated to diabetes and endocrinology, driven by the increasing prevalence of these conditions globally and the continuous pursuit of advancements in treatment and management.

The market for diabetes and endocrinology conferences is expanding due to several factors. The rising incidence of diabetes and endocrine disorders, lifestyle changes, and genetic predispositions contribute to the increasing demand for knowledge-sharing and collaboration within the medical community. This conference attracts endocrinologists, diabetologists, researchers, pharmaceutical companies, and healthcare professionals seeking insights into the latest research findings, treatment modalities, and technological innovations.

Key drivers for the growth of this market include the continuous evolution of diabetes management strategies, the integration of digital health technologies, and the emphasis on personalized medicine. The Diabetes and Endocrinology Conference serves as a hub for networking, interdisciplinary collaboration, and exposure to cutting-edge research.

Pharmaceutical companies often leverage the conference to showcase their latest medications, therapies, and technologies related to diabetes and endocrinology. As the global burden of diabetes and endocrine disorders continues to rise, the market for conferences in this field is expected to witness sustained growth. The conference will likely play a crucial role in advancing medical knowledge, fostering collaborations, and ultimately improving patient outcomes in the realm of diabetes and endocrinology.

– Quick Contact –